Please join us for a broader exploration of targeted interventions that provide real promise for reducing health disparities, limiting or delaying the onset of chronic health conditions, and improving the performance of the US health care system.
We need to consider new models for funding the delivery of curative treatments if we are going to encourage the development of such technologies and enable their efficient adoption. Only by changing our economic constructs are we going to realize the full public health benefit of the curative treatments in development.
Enactment of the ACA has not ended the US debate over health care reform, or the debate over how to improve health care for the poor. There were many problems with providing the poor with access to care before the ACA, and the new law will not make those problems disappear. But an alternative plan will not be easy to enact, either.
Exactly how many of the actual provisions of the ACA will be implemented and enforced still remains subject to change. But what comes through clearly is that employers remain engaged in finding better options through and around the evolving regulatory maze of Obamacare.
It is not possible to displace Obamacare without advancing a credible alternative. Simply repealing the law implies a reversion to the pre-Obamacare status quo, which had its own set of problems.
Is it possible for more Republican-led state governments to expand their Medicaid programs without politically endorsing the extension of ObamaCare under the Affordable Care Act? Indiana Gov. Mike Pence (R) says he can, but he hasn't convinced a number of conservative Republican critics.
Obamacare’s unpopularity has created a historic political opportunity for the law’s opponents. The public is thirsting for credible alternatives. But that does not mean that advancing a replacement plan is entirely without political risk.
Where is Obamacare headed? I tried to answer that question in a talk today at an advanced research seminar on Healthcare and the Regulatory State sponsored by the Institute for Humane Studies and Mercatus Center.
The first year’s enrollment in Obamacarecan be best understood as an exercise in doing whatever was necessary to get people on the program, no matter the consequences. And one very likely consequence is that taxpayers will end with a hefty bill for many improperly paid subsidies.
Please join AEI as the chief actuary for Medicare summarizes the report’s results, followed by a panel discussion of what those spending trends are likely to mean for seniors, taxpayers, the health industry, and federal policy.
Please join us as four of Washington’s most distinguished political observers will revisit the Watergate hearings and discuss reforms that followed.